News | Cardiovascular Business | February 25, 2016

GlobalData: Toshiba Medical Attractive Investment in Diagnostic Imaging Market

Canon and Fujifilm among top early bidders looking to expand into CT and MRI markets

Toshiba, investment opportunity, GlobalData analyst, Japan

February 25, 2016 — Investing in Toshiba Medical, which is seeking potential partners, is likely to deliver strong returns for companies looking to expand into the diagnostic imaging space, according to an analyst with research and consulting firm GlobalData. This could be particularly attractive in the Japanese market, according to the analyst.  

Thanks to a growing population with a steady demand for non-invasive diagnostic procedures, imaging devices have remained a lucrative investment, and GlobalData forecasts that the global diagnostic imaging market will be valued at $42.4 billion by 2020.

As Sarah Janer, GlobalData’s analyst covering medical devices, explained: “Toshiba Medical is a steady performer and its sales make up 10 percent of the thriving global market, which is tempting for companies looking to break into diagnostic imaging.

“Japanese firms are especially interested, as Toshiba Medical possesses 19.2 percent of the diagnostic imaging market in Japan. Canon Inc. and Fujifilm are stepping up to bid, and while both offer digital radiography devices, heavy investment in Toshiba Medical could expand their range to computed tomography (CT) and magnetic resonance imaging (MRI) systems.”

GlobalData estimates that the current markets for CT and MRI devices are expanding at compound annual growth rates of 14.3 and 10.4 percent, respectively.

Janer noted: “Investment opportunities are so attractive that Toshiba’s CEO Masashi Muromachi has hinted at already receiving opening bids significantly higher than the reported asking price of $3 billion for an 80 percent share. Canon and Fujifilm have partnered with other firms to improve the strength of their bid, demonstrating a strong eagerness to invest.

“Certainly, as both companies have less than a 3 percent share of the global diagnostic imaging market, a buyout could significantly boost their chances of competing with imaging titans like Siemens or GE Healthcare.”

Although Toshiba ranks fourth for global market share, collaboration could lead to innovation and some fierce competition down the road, depending on what percentage of Toshiba Medical is sold off.

Janer continued: “A 51 percent percent company share could result in some collaboration, but Toshiba’s restructuring plans would need to succeed. Full investment would result in a more stable outlook and a market share increase of up to 20 percent for the successful buyer, according to GlobalData.” 

For more information: www.globaldata.com

Related Content

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

News | Cardiovascular Business | July 08, 2020
July 8, 2020 – Philips Healthcare and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service agree
Medicare will pay for telehealth virtual doctor visits during the duration of the coronavirus COVID-19 outbreak.
News | Cardiovascular Business | March 17, 2020
March 17, 2020 — The Trump Administration today announced expanded Medicare telehealth coverage that will enable bene
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Cardiovascular Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
 Cath Lab Philips Azurion angiography PCI
News | Cardiovascular Business | December 30, 2019
December 30, 2019 — Most patients do not understand or recall information given to them before heart procedures.
Siemens Healthineers Acquires ECG Management Consultants
News | Cardiovascular Business | November 11, 2019
November 11, 2019 — ECG Management Consultants, a leading U.S.
Videos | Cardiovascular Business | September 30, 2019
A discussion with Ruth Fisher, MBA, vice president of the...
Scranton Gillette Communications Names Diagnostic and Interventional Cardiology Group Publisher and Integrated Media Consultant

Diane Vojcanin (left) was named vice president, group publisher, healthcare group, overseeing Imaging Technology News (ITN) and Diagnostic and Interventional Cardiology (DAIC). Andreja Slapsys (right) was named a healthcare group integrated media consultant.

News | Cardiovascular Business | September 06, 2019
Business-to-business communications company Scranton Gillette Communications has named Diane Vojcanin as vice president...
FDA Opens Proposal Solicitation Period for 2020 Experiential Learning Program
News | Cardiovascular Business | July 17, 2019
The U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) announced the 2020...